Life ScienceCompany
Delenex Therapeutics AG Ownership
Who owns Delenex Therapeutics AG?
Delenex Therapeutics AG is owned by Kuur Therapeutics. It was acquired on July 12, 2016.
Delenex Therapeutics AG Business Overview
Where is Delenex Therapeutics AG headquartered?
Delenex Therapeutics AG is headquartered in Schlieren, Switzerland.
What sector is Delenex Therapeutics AG in?
Delenex Therapeutics AG is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 296 acquisitions of life science companies in 2016, including 34 acquisitions by private equity firms, and 262 by strategics.